Human Metapneumovirus Circulation in the United States, 2008 to 2014
- PMID: 27244790
- DOI: 10.1542/peds.2015-2927
Human Metapneumovirus Circulation in the United States, 2008 to 2014
Abstract
Background: Human metapneumovirus (HMPV) infection causes respiratory illness, including bronchiolitis and pneumonia. However, national HMPV seasonality, as it compares with respiratory syncytial virus (RSV) and influenza seasonality patterns, has not been well described.
Methods: Hospital and clinical laboratories reported weekly aggregates of specimens tested and positive detections for HMPV, RSV, and influenza to the National Respiratory and Enteric Virus Surveillance System from 2008 to 2014. A season was defined as consecutive weeks with ≥3% positivity for HMPV and ≥10% positivity for RSV and influenza during a surveillance year (June through July). For each virus, the season, onset, offset, duration, peak, and 6-season medians were calculated.
Results: Among consistently reporting laboratories, 33 583 (3.6%) specimens were positive for HMPV, 281 581 (15.3%) for RSV, and 401 342 (18.2%) for influenza. Annually, 6 distinct HMPV seasons occurred from 2008 to 2014, with onsets ranging from November to February and offsets from April to July. Based on the 6-season medians, RSV, influenza, and HMPV onsets occurred sequentially and season durations were similar at 21 to 22 weeks. HMPV demonstrated a unique biennial pattern of early and late seasonal onsets. RSV seasons (onset, offset, peak) were most consistent and occurred before HMPV seasons. There were no consistent patterns between HMPV and influenza circulations.
Conclusions: HMPV circulation begins in winter and lasts until spring and demonstrates distinct seasons each year, with the onset beginning after that of RSV. HMPV, RSV, and influenza can circulate simultaneously during the respiratory season.
Copyright © 2016 by the American Academy of Pediatrics.
Similar articles
-
Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologic and clinical features.Pediatr Infect Dis J. 2008 May;27(5):406-12. doi: 10.1097/INF.0b013e318162a164. Pediatr Infect Dis J. 2008. PMID: 18382388
-
Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses.J Med Virol. 2005 Jan;75(1):101-4. doi: 10.1002/jmv.20243. J Med Virol. 2005. PMID: 15543589
-
Biennial spring activity of human metapneumovirus in Austria.Pediatr Infect Dis J. 2008 Dec;27(12):1065-8. doi: 10.1097/INF.0b013e31817ef4fd. Pediatr Infect Dis J. 2008. PMID: 18978517
-
The distinguishing features of human metapneumovirus and respiratory syncytial virus.Rev Med Virol. 2010 Jul;20(4):245-60. doi: 10.1002/rmv.651. Rev Med Virol. 2010. PMID: 20586081 Review.
-
[Human metapneumovirus].Pathol Biol (Paris). 2009 Mar;57(2):133-41. doi: 10.1016/j.patbio.2008.04.005. Epub 2008 Jun 2. Pathol Biol (Paris). 2009. PMID: 18515017 Free PMC article. Review. French.
Cited by
-
Demographics, Clinical Presentation and Outcome of Metapneumovirus Infection in Adults: A Case Series Analysis at Scarborough General Hospital, United Kingdom.Cureus. 2024 Nov 8;16(11):e73292. doi: 10.7759/cureus.73292. eCollection 2024 Nov. Cureus. 2024. PMID: 39524165 Free PMC article.
-
Interferon Epsilon-Mediated Antiviral Activity Against Human Metapneumovirus and Respiratory Syncytial Virus.Vaccines (Basel). 2024 Oct 21;12(10):1198. doi: 10.3390/vaccines12101198. Vaccines (Basel). 2024. PMID: 39460364 Free PMC article.
-
Changes in the epidemiological patterns of respiratory syncytial virus and human metapneumovirus infection among pediatric patients and their correlation with severe cases: a long-term retrospective study.Front Cell Infect Microbiol. 2024 Sep 2;14:1435294. doi: 10.3389/fcimb.2024.1435294. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39286815 Free PMC article.
-
Determining the timing of respiratory syncytial virus (RSV) epidemics: a systematic review, 2016 to 2021; method categorisation and identification of influencing factors.Euro Surveill. 2024 Feb;29(5):2300244. doi: 10.2807/1560-7917.ES.2024.29.5.2300244. Euro Surveill. 2024. PMID: 38304952 Free PMC article.
-
Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus.Hum Vaccin Immunother. 2023 Dec 15;19(3):2293300. doi: 10.1080/21645515.2023.2293300. Epub 2024 Jan 3. Hum Vaccin Immunother. 2023. PMID: 38172569 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous

